Frankfurt, 11 June 2013. Digital publishing provider PressMatrix GmbH successfully closed a Series A financing round, led by PDV Inter-Media Venture. Existing investors High-Tech Gruenderfonds, LBBW Venture and Vilitas also participated in this financing round.
Frankfurt, 11 March 2013. Following its strategy to consolidate the European market, Hofmann S.L., one of the leading European companies in the print-on-demand market for end-consumers, has acquired a majority stake in posterjack GmbH. Florian Stadler and Johannes Busch, founders and managing directors of posterjack, will continue to manage the company and will remain shareholders with a relevant stake.
December 2012. CFP – now ACXIT Capital Partners – advised the shareholders of Retail Info s.r.o.in the trade sale to Mafra a.s. For further information please refer to the following press release of MCI Group, 47% shareholder of Retail Info.
Neuilly-sur-Seine, 15 November 2012. Thales announces the acquisition of Sysgo AG, the European leader in safe and secure operating systems required for markets served by the Group such as aeronautics, space, transport, defence and security. Sysgo employs 80 people in Germany, France and the Czech Republic.
06 November 2012. Trademob, the leading data-driven mobile app marketing platform, announced today a Series B investment of $15 million led by technology growth equity investor Kennet Partners.
Frankfurt, 16 October 2012. HolidayInsider AG (“HolidayInsider”) today announced a significant minority investment by DERTOUR, a leading travel organisation in Germany and part of the REWE Group. As part of its strategic re-positioning, REWE Group’s Travel & Tourism Division has initially acquired 43% of the shares in HolidayInsider.
September 2012. CFP BioConnect – now ACXIT Capital Partners – acted as sole financial advisor to cerbomed GmbH (cerbomed, the “Company”), based in Erlangen, in a financing round led by US company Cyberonics, Inc. (NASDAQ: CYBX), the market leader in medical devices for the treatment and management of epilepsy. The initial investment of Cyberonics will amount to €2 million, but could be increased to up to €5.5 million, once certain milestones are achieved.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.